https://www.indianpharmapost.com/telangana-fires-up-biologics-innovation-debuts-indias-first-single-use-bioprocess-scale-up-hub-183382025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-fdas-final-approval-for-verapamil-hydrochloride-er-tablets-183532025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/gilead-delivers-groundbreaking-hiv-prevention-drug-to-eswatini-zambia-183522025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/ge-healthcare-to-acquire-intelerad-for-23-billion-expanding-cloud-and-ai-imaging-footprint-183512025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbott-to-acquire-exact-sciences-for-21-billion-183502025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/alzheimers-testing-goes-painless-homebound-with-neurogen-tasso-partnership-183492025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/sorcero-scores-425m-series-b-to-supercharge-ai-driven-life-sciences-insights-183482025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/solventum-to-acquire-acera-surgical-in-725-million-deal-183472025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbott-issues-urgent-correction-for-freestyle-libre-3-sensors-amid-safety-concerns-183462025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisks-semaglutide-fails-to-slow-alzheimers-progression-in-phase-3-trials-183452025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-kgaas-cladribine-capsules-gain-fda-fast-track-for-rare-neuromuscular-disorder-183442025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/eli-lilly-to-spotlight-groundbreaking-btk-inhibitor-jaypirca-at-ash-2025-183432025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/thermo-fisher-opens-two-new-centers-in-hyderabad-183422025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/eli-lilly-to-unveil-major-breast-cancer-data-at-sabcs-2025-183412025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/eu-clears-bristol-myers-squibbs-car-t-therapy-breyanzi-for-tough-to-treat-lymphoma-183402025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/brenntag-to-showcase-latest-pharma-innovation-at-cphi-india-2025-183392025-11-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/eris-lifesciences-consolidates-its-stake-in-swiss-parenterals-183542025-11-25T00:00:00+05:30always0.9